As part of an application to the EIC Pathfinder Open 2026 call, EU-based industrial partners are sought to support scale-up, regulatory development, and first-in-human clinical translation of innovative small-molecule modulators and targeted nanomedicine platforms. Dual-action technologies selectively influence mitochondrial and bacterial ion pathways to reprogram tumor immunity and gut microbiota, boosting the efficacy of anti-Programmed death-1 (PD-1) immunotherapy.
Ref. BRDE20260701021 Fabricante alemán de ingredientes para repostería y productos de postre busca socios internacionales para la fabricación por contrato de productos de marca blanca y de marca propia.
A German manufacturer of baking ingredients, desserts, decorative baking products, gelatine products, thickening agents and baking mixes seeks experienced food manufacturers for the production of products under private-label and branded concepts. The company is...
Jul 28, 2026
















